Two doses is only 2 weeks in, which is not enough time to confirm GI tolerance or to settle into your titration step
PEPTIDE SOURCES & SAFETY - My guest on the Huberman Lab podcast out now is Dr Abud Bakri, MD @abud_bakri We discuss peptides: BPC, GLPs (incl Retatrutide), GHK-Cu, Pinealon, Epitalon, TB500 and Thymosin, and more
Here's a breakdown of the big issues and power players you need to know to wrap your head around the fiery debate
- Nausea appears to be less common with long-acting than short-acting compounds
The FDAs own language makes it clear: Compounded drugs containing BPC-157 may pose risk for immunogenicity and may have complexities with regard to peptide-related impurities and API characterization. In plain terms, the FDA is worried about shady, unregulated research-use-only peptides sold online not about what happens when BPC-157 is responsibly compounded, tested for purity, and dispensed under medical supervision